Novo Nordisk
272,25 DKK
+6,53 %
1.024 følger denne virksomhed
NOVO B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Værdiansættelse
Resultatopgørelse
Kvartalsdata
Kvartalsdata
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Novo Nordisk
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Omsætning | 71.311,0 | 85.683,0 | 290.403,0 | 78.087,0 | 76.857,0 | 74.976,0 | 79.144,0 | 309.064,0 |
| EBITDA | 35.972,0 | 41.935,0 | 147.446,0 | 42.621,0 | 38.282,0 | 31.439,0 | 37.298,0 | 149.640,0 |
| EBIT | 33.822,0 | 36.737,0 | 128.339,0 | 38.791,0 | 33.449,0 | 23.682,0 | 31.736,0 | 127.658,0 |
| EBIT-% | 47,4 % | 42,9 % | 44,2 % | 49,7 % | 43,5 % | 31,6 % | 40,1 % | 41,3 % |
| Overskud før skat | 34.384,0 | 35.557,0 | 127.191,0 | 37.033,0 | 33.805,0 | 25.517,0 | 34.185,0 | 130.540,0 |
| Netto indkomst | 27.301,0 | 28.230,0 | 100.988,0 | 29.034,0 | 26.503,0 | 20.006,0 | 26.891,0 | 102.434,0 |